Report
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
Report documents
-
Executive summary of the final report
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Final report
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Documentation and appraisal of comments on the preliminary report
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Preliminary report
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Report plan version 2.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Documentation and appraisal of comments on the report plan version 1.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Amendment 1 to the report plan version 1.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
-
Report plan version 1.0
Long-acting insulin analogues in the treatment of diabetes mellitus type 2
Press releases
Long-acting insulin analogues in type 2 diabetes: advantage over human insulin not proven
Long-term effects of insulin detemir are not assessable / Evidence base is insufficient, even if unpublished data are considered
Additional information
IQWiG health information
Project details
- Project no.
- A05-03
- Commission
- Commission awarded on 22.02.2005 by the Federal Joint Committee (GBA).
- Report type
- Report
- Status
- Commission completed
- Department/Division
- Drug Assessment
- Topic
- Digestion, metabolism and hormones